IL163720A0 - Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents - Google Patents

Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents

Info

Publication number
IL163720A0
IL163720A0 IL16372003A IL16372003A IL163720A0 IL 163720 A0 IL163720 A0 IL 163720A0 IL 16372003 A IL16372003 A IL 16372003A IL 16372003 A IL16372003 A IL 16372003A IL 163720 A0 IL163720 A0 IL 163720A0
Authority
IL
Israel
Prior art keywords
migraine
therapy
treatment
agents
anticonvulsant derivatives
Prior art date
Application number
IL16372003A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL163720A0 publication Critical patent/IL163720A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16372003A 2002-02-26 2003-02-25 Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents IL163720A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35989402P 2002-02-26 2002-02-26
PCT/US2003/005463 WO2003072138A1 (en) 2002-02-26 2003-02-25 Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents

Publications (1)

Publication Number Publication Date
IL163720A0 true IL163720A0 (en) 2005-12-18

Family

ID=27663315

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16372003A IL163720A0 (en) 2002-02-26 2003-02-25 Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
IL163720A IL163720A (en) 2002-02-26 2004-08-24 Use of topiramate for the preparation of a medicament suitable for co-therapy with a triptan

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL163720A IL163720A (en) 2002-02-26 2004-08-24 Use of topiramate for the preparation of a medicament suitable for co-therapy with a triptan

Country Status (19)

Country Link
US (2) US20030225002A1 (xx)
EP (1) EP1478400A1 (xx)
JP (1) JP2005518439A (xx)
KR (1) KR101008326B1 (xx)
CN (1) CN100352506C (xx)
AU (1) AU2003213242A1 (xx)
BR (1) BR0307951A (xx)
CA (1) CA2419989A1 (xx)
HK (1) HK1080731A1 (xx)
HR (1) HRP20040846A2 (xx)
IL (2) IL163720A0 (xx)
MX (1) MXPA04008259A (xx)
NO (1) NO20043984L (xx)
NZ (1) NZ534874A (xx)
PL (1) PL372393A1 (xx)
RU (1) RU2004126093A (xx)
UA (1) UA81110C2 (xx)
WO (1) WO2003072138A1 (xx)
ZA (1) ZA200407729B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
CA2556424A1 (en) * 2004-02-17 2005-09-01 Sepracor Inc. Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites
US20060233892A1 (en) * 2005-04-19 2006-10-19 Curt Hendrix Topiramate compositions for treatment of headache
US20060252745A1 (en) * 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
FR2890564B1 (fr) * 2005-09-09 2007-10-19 Servier Lab Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent
JP5580042B2 (ja) * 2006-04-13 2014-08-27 ヌパス インコーポレイテッド 抗片頭痛化合物の送達のための経皮的方法およびシステム
JP2009535336A (ja) * 2006-04-25 2009-10-01 コーワ ファーマシューティカルズ アメリカ，インコーポレイティド 片頭痛治療用の固定組合せ剤形
US9744137B2 (en) 2006-08-31 2017-08-29 Supernus Pharmaceuticals, Inc. Topiramate compositions and methods of enhancing its bioavailability
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
EP2394643B1 (en) 2006-11-17 2015-09-02 Supernus Pharmaceuticals, Inc. Sustained-release formulations of topiramate
CN102114002B (zh) * 2006-12-04 2016-05-11 苏佩努斯制药公司 托吡酯的增强的立即释放制剂
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
CA2737135C (en) * 2008-09-17 2017-07-11 The Mclean Hospital Corporation Methods and kits for treating cluster headache disorders
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
WO2018067330A1 (en) * 2016-10-06 2018-04-12 Baylor College Of Medicine Photochromatic modulation with fluorescein for the treatment of photo-oculodynia and blepharospasm
CN113677348A (zh) * 2019-04-15 2021-11-19 费林药业公司 偏头痛的治疗

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
AU651244B2 (en) * 1991-09-19 1994-07-14 Mcneilab, Inc. Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
AU4078897A (en) * 1996-08-23 1998-03-06 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20020015713A1 (en) * 1996-10-24 2002-02-07 Murdock Robert W. Methods and transdermal compositions for pain relief
JP2001513803A (ja) * 1997-03-03 2001-09-04 ラボラトワール ルミレア 植物抽出物組成物、その製造方法、及びそれを含む医薬組成物
US5855907A (en) * 1997-03-24 1999-01-05 Peyman; Gholam A. Method of treatment of migraine
US5935933A (en) * 1997-07-16 1999-08-10 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating neuropathic pain
US5760007A (en) * 1997-07-16 1998-06-02 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating neuropathic pain
GB9720270D0 (en) * 1997-09-25 1997-11-26 Pharmagene Lab Limited Medicaments for the treatment of migraine
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
AU771388B2 (en) * 1999-01-19 2004-03-18 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating cluster headaches
HUP0203198A3 (en) * 1999-08-20 2005-07-28 Ortho Mcneil Pharm Inc Pharmaceutical composition comprising a tramadol material and an anticonvulsant drug, process for its preparation and its use

Also Published As

Publication number Publication date
MXPA04008259A (es) 2005-05-27
CN1646168A (zh) 2005-07-27
AU2003213242A1 (en) 2003-09-09
CN100352506C (zh) 2007-12-05
JP2005518439A (ja) 2005-06-23
US20070099849A1 (en) 2007-05-03
WO2003072138A1 (en) 2003-09-04
EP1478400A1 (en) 2004-11-24
NO20043984L (no) 2004-09-23
NZ534874A (en) 2007-03-30
HK1080731A1 (en) 2006-05-04
UA81110C2 (en) 2007-12-10
RU2004126093A (ru) 2005-04-10
CA2419989A1 (en) 2003-08-05
ZA200407729B (en) 2006-06-28
BR0307951A (pt) 2004-12-21
IL163720A (en) 2012-06-28
PL372393A1 (en) 2005-07-25
HRP20040846A2 (en) 2005-06-30
KR20040091074A (ko) 2004-10-27
US20030225002A1 (en) 2003-12-04
KR101008326B1 (ko) 2011-01-13

Similar Documents

Publication Publication Date Title
IL163720A0 (en) Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
AU2003286567A8 (en) Methods for the treatment of skin disorders
HK1079789A1 (zh) 血管靜態毒性試劑及其使用方法
HK1156521A1 (en) Methods of treating pre-eclampsia
HK1074784A1 (en) Treatment of mucositis
PT1530466E (pt) Utilização de nintedanib para o tratamento de fibrose pulmonar
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
IL136960A0 (en) Combination therapy for the treatment of migraine
IL159879A0 (en) Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
AU2003251875A8 (en) Combination therapy for the treatment of neoplasms
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
GB0210741D0 (en) Methods of therapy
AP2004003174A0 (en) Treatment of water
AU2001285156A1 (en) Combination therapy for the treatment of migraine
GB0210264D0 (en) The treatment of pain and migraine headache
EP1539100A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
IL136025A0 (en) Combination therapy for the treatment of migraine
IL136962A0 (en) Combination therapy for the treatment of migraine
EP1573063A4 (en) TREATMENT OF LIVER DISEASES
EP1684795A4 (en) METHODS AND AGENTS FOR THE TREATMENT OF CANCER
IL136024A0 (en) Combination therapy for the treatment of migraine
PL371270A1 (en) Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
GB0221712D0 (en) Methods of treatment
GB0400094D0 (en) The method of treating tuberculosis
EP1488800A4 (en) MEDICINE FOR THE TREATMENT OF PROTOCOL DISEASES